Bernicker Environmental Oncology

Theory and Impact
1. Auflage 2023
ISBN: 978-3-031-33750-5
Verlag: Springer International Publishing
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 321 Seiten, eBook

This book covers the wide range of malignant illness and where they intersect with environmental factors. Chapters explore the importance of acknowledging and dealing with the societal implications of anthropogenic climate change, a wider appreciation of the many ways that human industry and activity is changing the environment and contributing to human disease is imperative. In addition to how particular exposures relate to certain malignancies, the book explores historical events that led to the development of cancers in order to help policy makers and patient advocates understand where we have been when considering future initiatives. It also discusses the disparities involved in environmental toxin exposure and look at these cancers in light of the need to reduce cancer disparities. 
Given the ongoing ecological crisis from climate change and expanding human population and industrialization, this book examines pollution and ecological change to impacts and where human disease can be prevented.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Bernicker, Eric H.

Inhaltsverzeichnis

Molecular mechanisms of environmental oncogenesis.- Air pollution and lung cancer.- Lost opportunities: deforestation, sick oceans and fewer drugs from nature.- Meat consumption: Alcoholism, dietary choice and cancer.- Tobacco, second-hand smoke and cancer.- Sun exposure and skin cancer.- Climate Change and Cancer.- Pesticides and cancer.- Environmental justice, equity and cancer.- Asbestos, mining, mesothelioma and lung cancer.- Legal issues in cancer and pollution.- Agent orange and cancer.- Nuclear weapons and cancer.

Über Autor(innen)

Eric H. Bernicker MDNeal Cancer Center, Houston Methodist HospitalHouston, TX, USADr. Bernicker earned his medical degree from Baylor College of Medicine in Houston, TX in 1990. Subsequently, he completed his residency at Baylor Affiliated Hospitals and was chief medical resident at Ben Taub General Hospital from 1993–1994. Dr. Bernicker held a faculty appointment at Baylor College of Medicine as a clinical assistant professor from 1996–2012 before joining the Houston Methodist Cancer Center in January 2013, where he serves as director of Medical Thoracic Oncology. As a physician-scientist, Dr. Bernicker oversees the expansion of clinical trials at The Methodist Hospital relating to Thoracic Oncology with all stages of disease, a combination of cooperative trials, industry trials of novel targeted agents and investigator initiated trials looking at reversing immunotherapy resistance.